AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE
AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.
Keep up to date on AgNovos events and related news
It is with great pleasure that AgNovos Healthcare announces the recipients of this year’s ESCEO-AgNovos Young Investigator Award presented at World Congress on Osteoporosis in March 2022.
AgNovos Healthcare will participate in World Congress on Osteoporosis from March 24-27th.
AgNovos Healthcare will participate in American Society of Spine Radiology’s 25th annual symposium from February 23-27th in Austin, Texas.
AgNovos Healthcare will participate in this year’s Belgian Bone Club congress on January 22nd.
AgNovos Healthcare is pleased to announce the completion of enrollment for its CONFIRM clinical study.